RX

Renhuan Xu, PhD

CSO, Co-founder

Pinion Immunotherapeutics

Pinion Immunotherapeutics Pipeline

DrugIndicationPhase
ARV-2001HPV-16 PrecancerPreclinical
DCAR-001AML ImmunotherapyPreclinical
ARV-1004EBV TherapeuticPreclinical
ARV-1003HBV TherapeuticPreclinical
UndisclosedHSV TherapeuticPreclinical